Y-mAbs Therapeutics, Inc. (YMAB)

NASDAQ: YMAB · Real-Time Price · USD

5.11

+0.03 (0.59%)

At close: Jun 10, 2025, 4:00 PM

5.06

-0.05 (-0.98%)

After-hours: Jun 10, 2025, 6:09 PM EDT

Y-mAbs Therapeutics Market Cap

Y-mAbs Therapeutics has a market cap or net worth of $231.46 million as of June 10, 2025. Its market cap has decreased by -57.46% in one year.

Market Cap

231.46M

Enterprise Value

171.75M

1-Year Change

-57.46%

Ranking

#3597

Market Cap Chart

Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $231.46M, a decrease of -70.95%. That is a compound annual growth rate of -16.79%.

Market Cap History

Date	Market Cap	% Change
Jun 10, 2025	231.46M	-34.00%
Dec 31, 2024	350.70M	17.88%
Dec 29, 2023	297.50M	39.61%
Dec 30, 2022	213.10M	-69.88%
Dec 31, 2021	707.47M	-64.73%
Dec 31, 2020	2.01B	61.56%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	724.64B
Johnson & Johnson	376.43B
Novo Nordisk	353.20B
AbbVie	334.73B
UnitedHealth Group	275.58B
Abbott Laboratories	233.36B
Novartis AG	232.35B
AstraZeneca	227.75B

Market Cap Rankings